Drugmakers locked in dealmaking flurry
September 12th, 2008 by 
admin Bristol-Myers ‘disappointed’ over ImClone’s rejection of its $60 per deal effort patch King Pharmaceuticals intensifies efforts to get curb of Alpharma
Posted in Pharmaceuticals | 